Barrett & Company’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Barrett & Company's PFE Position: Q3 2026 in Review
Barrett & Company reduced its Pfizer (PFE) stake by 4.9% in Q3 2026, selling an estimated $17K and leaving 12,325 shares worth $352K. The position accounts for 0.1% of the portfolio, ranked #116.
Barrett & Company first reported a position in PFE in Q3 2022 and has held it in 17 quarters since. The position peaked at $799K in Q4 2022. 980 funds tracked by Wall St. Rank hold PFE as of Q3 2026.
- Barrett & Company held 12,325 shares of Pfizer worth $352K as of Q3 2026.
- Barrett & Company sold 641 Pfizer shares in Q3 2026, an estimated $17K.
- Pfizer made up 0.1% of Barrett & Company's portfolio in Q3 2026, its #116 holding.
- Barrett & Company first reported a position in Pfizer in Q3 2022 and has held it in 17 quarters since.
- Barrett & Company's Pfizer position peaked at $799K in Q4 2022.
- 980 funds tracked by Wall St. Rank held Pfizer as of Q3 2026.
Based on Barrett & Company's 13F filing for Q3 2026, filed 22 Oct 2026.